Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025)

Not yet recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
HIV Infection
All Listed Sponsors
lead

ANRS, Emerging Infectious Diseases

OTHER_GOV

NCT06842706 - Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025) | Biotech Hunter | Biotech Hunter